Registration Filing
Logotype for RYTHM Inc

RYTHM (RYM) Registration Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for RYTHM Inc

Registration Filing summary

16 Dec, 2025

Company overview and business model

  • Operates a portfolio of hemp-derived THC products and licensed consumer brands, including beverages and edibles, distributed in the U.S. and Canada.

  • Brands include Señorita, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's, and Good Green; products are sold online, through retail, and via licensing agreements.

  • Recently exited the extraction and cultivation equipment businesses to focus on consumer packaged goods and brand licensing.

  • Acquired key intellectual property assets and entered into licensing and shared services agreements with Green Thumb Industries and its subsidiaries.

  • Finished goods are manufactured by third-party co-manufacturers; distribution is expanding through agreements with various partners.

Financial performance and metrics

  • As of December 12, 2025, public float was approximately $63.9 million, with 1,363,742 shares held by non-affiliates at a reference price of $46.84 per share.

  • Outstanding common stock totaled 2,149,128 shares, with significant warrants, options, and convertible notes outstanding.

  • Issued $90 million in secured convertible notes in 2024 and 2025, with conversion prices ranging from $3.158 to $29.475 and interest rates of 10% per annum.

  • Qualifies as a smaller reporting company, providing reduced disclosure and compliance requirements.

Use of proceeds and capital allocation

  • Net proceeds from offerings will be used for working capital, general corporate purposes, and potentially for acquisitions or strategic investments.

  • No specific allocation of proceeds; management has broad discretion in application.

  • Pending use, proceeds will be invested in short-term, investment-grade instruments.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more